GWPH - GW Pharmaceuticals Q3 2020 Earnings Preview
GW Pharmaceuticals (NASDAQ:GWPH) is scheduled to announce Q3 earnings results on Tuesday, November 3rd, before market open.The consensus EPS Estimate is -$0.06 (-50.0% Y/Y) and the consensus Revenue Estimate is $125.97M (+38.5% Y/Y).Analyst expects cost of product sales of $11.5M; R&D expense of $51.5M; SG&A of $85.5M.Over the last 2 years, GWPH has beaten EPS estimates 50% of the time and has beaten revenue estimates 75% of the time.Over the last 3 months, EPS estimates have seen 1 upward revision and 6 downward. Revenue estimates have seen 0 upward revisions and 13 downward.
For further details see:
GW Pharmaceuticals Q3 2020 Earnings Preview